Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1121results about How to "Raise transfer to" patented technology

Exposure apparatus and device manufacturing method

Liquid is supplied by a supply mechanism to a space between a lens and a wafer via a supply nozzle on one side of the lens, and the liquid is recovered by a recovery mechanism via a recovery pipe on the other side of the lens. When the supply and the recovery of the liquid are performed in parallel, a predetermined amount of liquid (exchanged at all times) is held between the lens and the substrate on the stage. Accordingly, when exposure (pattern transfer on the substrate) is performed in this state, an immersion method is applied and a pattern is transferred with good precision onto the substrate. In addition, in the case the liquid leaks out from under the lower edge of a peripheral wall, the liquid that could not be recovered is recovered by an auxiliary recovery mechanism via a slit. And, by such operations, the substrate is freed from the residual liquid on the substrate.
Owner:NIKON CORP

Spatially decoupled twin secondary coils for optimizing transcutaneous energy transfer (TET) power transfer characteristics

An implantable device, such as an infuser device for bidirectional hydraulically controlling a medical artificial sphincter, enhances power transfer characteristics to a secondary coil thereby allowing implantation to greater physical depths and / or enclosing the secondary coil within a housing of the infuser device. The enhanced power transfer is achieved with multiple coils that are longitudinally aligned and physical and electrical parallel to form the secondary loop of a transcutaneous energy transfer system (TET) instead of a single coil. It better optimizes the power transfer from a parallel tuned tank circuit primary coil to an implanted secondary series tuned tank circuit coil.
Owner:ETHICON ENDO SURGERY INC

Systems and methods for monitoring health and delivering drugs transdermally

The present invention pertains to a system and method for transdermal sampling, comprising: at least one sampler for retrieving and transferring at least one analyte obtained transdermally from the skin of a subject; at least one detector system for identifying and quantifying said at least one analyte; and at least one logic module for (i) receiving and storing input data from said at least one detector, (ii) relating the input data to other data obtained from the subject, (iii) displaying output information, (iv) transmitting the output information to another system, and (v) controlling the operation of said at least one sampler and at least one detector.
Owner:DERMAL SYST INT +2

System and method for mapping file block numbers to logical block addresses

A system and method for mapping file block numbers (FBNs) to logical block addresses (LBAs) is provided. The system and method performs the mapping of FBNs to LBAs in a file system layer of a storage operating system, thereby enabling the use of clients in a storage environment that have not been modified to incorporate mapping tables. As a result, a client may send data access requests to the storage system utilizing FBNs and have the storage system perform the appropriate mapping to LBAs.
Owner:NETWORK APPLIANCE INC

Transfection of blood cells with mRNA for immune stimulation and gene therapy

The present invention relates to a pharmaceutical composition containing blood cells or haemopoietic cells, e.g. red blood cells (erythrocytes), granulocytes, mononuclear cells (PBMCs) and / or blood platelets, in combination with a pharmaceutically acceptable excipient and / or vehicle, wherein the cells are transfected with at least one mRNA comprising at least one region coding for at least one antigen. The invention further discloses a method of preparing the aforesaid pharmaceutical composition and the use of blood cells transfected in this way for the preparation of drugs or pharmaceutical compositions for immune stimulation against the antigens encoded by the mRNA. The subjects according to the invention are used especially for the therapy and / or prophylaxis of carcinoses or infectious diseases and can also be employed in gene therapy.
Owner:CUREVAC AG

Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages

The present invention includes dry powder inhalers and associated multi-dose dry powder packages for holding inhalant formulated dry powder substances and associated fabrication and dispensing methods. The multi-dose package can include a platform body comprising at least one thin piezoelectric polymer material layer defining at least a portion of a plurality of spatially separated discrete elongate dry powder channels having an associated length, width and height; and a metallic material attached to selected portions of the piezoelectric polymer material including each of the regions corresponding to the elongate dry powder channels to, in operation, define active energy releasing vibratory channels. In operation, the elongate channels can be selectively individually activated to vibrate upon exposure to an electrical input.The dry powder inhaler includes an elongate body having opposing first and second outer primary surfaces with a cavity therebetween and having opposing top and bottom end portions and a multi-dose sealed blister package holding a plurality of discrete meted doses of a dry powder inhalable product located in the cavity of the elongate body. The inhaler also includes an inhalation port formed in the bottom end portion of the elongate body, the inhalation port configured to be in fluid communication with at least one of the discrete meted doses during use and a cover member that is pivotably attached to the elongate body so that it remains attached to the body during normal operational periods of use and moves to a first closed position to overlie the inhalation port at the bottom end portion of the body during periods of non-use and moves to a second open position away from the inhalation port during periods of use to allow a user to access the inhalation port.
Owner:ORIEL THERAPEUTICS INC

Hydrogen and elemental carbon production from natural gas and other hydrocarbons

Diatomic hydrogen and unsaturated hydrocarbons are produced as reactor gases in a fast quench reactor. During the fast quench, the unsaturated hydrocarbons are further decomposed by reheating the reactor gases. More diatomic hydrogen is produced, along with elemental carbon. Other gas may be added at different stages in the process to form a desired end product and prevent back reactions. The product is a substantially clean-burning hydrogen fuel that leaves no greenhouse gas emissions, and elemental carbon that may be used in powder form as a commodity for several processes.
Owner:BATTELLE ENERGY ALLIANCE LLC

Fan assembly

A bladeless fan assembly for creating an air current includes a nozzle mounted on a base housing a device for creating an air flow. The nozzle includes an interior passage for receiving the air flow and a mouth for emitting the air flow. The nozzle defines, and extends about, an opening through which air from outside the fan assembly is drawn by the air flow emitted from the mouth. The nozzle also includes a heater for heating the air flow upstream of the mouth.
Owner:DYSON TECH LTD

Transfection of blood cells with mRNA for immune stimulation and gene therapy

The present invention relates to a pharmaceutical composition containing blood cells or haemopoietic cells, e.g. red blood cells (erythrocytes), granulocytes, mononuclear cells (PBMCs) and / or blood platelets, in combination with a pharmaceutically acceptable excipient and / or vehicle, wherein the cells are transfected with at least one mRNA comprising at least one region coding for at least one antigen. The invention further discloses a method of preparing the aforesaid pharmaceutical composition and the use of blood cells transfected in this way for the preparation of drugs or pharmaceutical compositions for immune stimulation against the antigens encoded by the mRNA. The subjects according to the invention are used especially for the therapy and / or prophylaxis of carcinoses or infectious diseases and can also be employed in gene therapy.
Owner:CUREVAC AG

Multi-Element Resonant Converters

A resonant switched power converter having switching frequency controlled in response to an output voltage thereof achieves over-current protection such as at start-up or under short circuit conditions using a resonant tank circuit which provides a notch filter in addition to a band pass filter. A additional band pass filter provided in the resonant tank circuit achieves increased power transfer to a load and reduced circulating resonant currents and conduction losses. The inductances of the preferred LCLCL tank circuit or other tank circuit with two pass band filters and a notch filter may be integrated into a single electrical component.
Owner:VIRGINIA TECH INTPROP INC

Apparatus and methods for micro-transfer-printing

In an aspect, a system and method for assembling a semiconductor device on a receiving surface of a destination substrate is disclosed. In another aspect, a system and method for assembling a semiconductor device on a destination substrate with topographic features is disclosed. In another aspect, a gravity-assisted separation system and method for printing semiconductor device is disclosed. In another aspect, various features of a transfer device for printing semiconductor devices are disclosed.
Owner:X DISPLAY CO TECH LTD

Implantable transducer with transverse force application

An implantable hearing aid transducer is provided that allows providing movement for stimulation purposes in at least first and second directions. This allows for moving an auditory component in a direction that may be substantially aligned with a natural direction of movement for the auditory component. In one arrangement, a middle ear transducer having an elongated vibratory member that extends into a patient's tympanic cavity is operative to move a tip of the vibratory member in at least first and second directions. A first direction may be along a long axis of the vibratory member while a second direction may be in a direction that is at least partially transverse to the long axis of the vibratory member. Further, the transducer may be positionable to provide alignment of the vibratory member such that the transverse direction of movement is substantially aligned with a direction of natural movement of a middle ear component (e.g. ossicles bone) to be stimulated.
Owner:COCHLEAR LIMITED

Stem cell therapy for cardiac valvular dysfunction

Disclosed are methods, compounds and compositions useful for treatment of a patient with valvular dysfunction. The invention relates to using stem cells, modified stem cells, derivatives thereof, and agents stimulatory to stem cells in order to substantially ameliorate, and in some cases induce a therapeutic benefit, to a patient suffering from a dysfunction of the mitral, aortic, tricuspid, or pulmonary valve. In some embodiments the invention treats the valve dysfunction itself, whereas in other embodiments treatment of associated cardiac structures is performed. Furthermore, in other embodiments the invention permits physiological compensation for the valve dysfunction, prolonging the time until surgical intervention is needed.
Owner:MEDISTEM LAB

Power supply controller for exercise equipment drive motor

A combined power supply and driver control module includes rectifier circuitry, switching circuitry, and driver circuitry for providing output power to a load. Rectified output from an input power source is used to produce a DC power. The switching circuitry receives the DC power and modulates the input current drawn from the power source. An intelligent control module includes control circuitry, such as a digital processor, for controlling the switching circuitry. Power factor is improved by modulating the input current to be closer in phase with the voltage of the power source. Also disclosed is a power factor correction circuit in which a digital processor reads waveform values from a lookup table and modulates the input current waveform based on the values. A zero crossing detector connected to the input power source may direct the digital processor when to commence reading values from the lookup table.
Owner:PRECOR

Portable fluorescence detection system and microassay cartridge

Disclosed is a compact, microprocessor-controlled instrument for fluorometric assays in liquid samples, the instrument having a floating stage with docking bay for receiving a microfluidic cartridge and a scanning detector head with on-board embedded microprocessor operated under control of a ODAP daemon resident in the detector head for controlling source LEDs, emission signal amplification and filtering in an isolated, low noise, high-gain environment within the detector head. Multiple optical channels may be incorporated in the scanning head. In a preferred configuration, the assay is validated using dual channel optics for monitoring a first fluorophore associated with a target analyte and a second fluorophore associated with a control. Applications include molecular biological assays based on PCR amplification of target nucleic acids and fluorometric assays in general, many of which require temperature control during detection.
Owner:PERKINELMER HEALTH SCIENCES INC

Inductive power distribution system

Inductive power transfer across an extended gap (100) from a primary conductor (119) is provided by means of a resonant intermediate loop comprised of capacitor (118) with inductor (117) carrying a larger resonating current, that can in turn generate an inductive field to be collected by a pickup coil (120). This process and device find application in an electroluminescent advertising panel.
Owner:AUCKLAND UNISERVICES LTD

Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles

InactiveUS20090130756A1Simplifies and improves methodRaise transfer toPowder deliveryDead animal preservationParticulatesCross-link
The present invention is directed to methods of cryopreserving cells and cryopreserved cells prepared according to the methods. In specific embodiments, the method comprises combining cells with a cross-linked hydrogel matrix in particulate form, the matrix comprising a polyglycan cross-linked to a polypeptide and subjecting the combination to cryopreservation conditions. In further embodiments, the invention provides cell-seeded compositions comprising cells and a cross-linked bioactive hydrogel matrix in particulate form, the matrix comprising a polyglycan cross-linked to a polypeptide, wherein the composition has been subjected to cryopreservation conditions. The cryopreserved cells can be thawed and used in methods of treatment without the need for intervening steps to make the cells viable for in vivo use.
Owner:PIONEER SURGICAL TECH INC

Methods for producing composite webs with reinforcing discrete polymeric regions

Methods of manufacturing composite webs including a substrate with one or more reinforcing discrete polymeric regions located on or within the composite web are disclosed. Molten nonelastomeric thermoplastic material of the discrete polymeric region is forced against the substrate by a transfer roll. If the substrate is porous, fibrous, etc., a portion of the nonelastomeric thermoplastic composition may infiltrate the substrate and / or encapsulate fibers of the substrate.
Owner:3M INNOVATIVE PROPERTIES CO

System and method for a communication network

A method and system for transmitting information between a sending means and a receiving means using packets for information transmission. The receipt of transmitted packets is acknowledged and unacknowledged packets are retransmitted from the sending means. The amount of transmitted unacknowledged information or the number of consecutive unacknowledged packets is detected, and the reason for information or packet loss is determined based on the amount of transmitted unacknowledged information or the number of consecutive unacknowledged packets. This amount is compared with a path maximum transmission unit (PMTU) to determine the reason for loss. A single or small number of unacknowledged packets is determined to be a result of Bit Error Rate (BER), whereas a larger number of consecutive unacknowledged packets may be determined to be congestion. Congestion control parameters are kept unchanged when the reason for loss is caused by Bit Error Rate (BER), whereas control parameters are changed when the reason for loss is congestion.
Owner:CONVERSANT WIRELESS LICENSING LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products